R&D efforts at Boehringer Ingelheim Vetmedica, Inc., are part of a global animal health strategy. We focus on two target areas: vaccines to aid in disease prevention and pharmaceutical products to treat chronic diseases in livestock and companion animals around the world.

Numerous partnerships with academic institutions and Boehringer Ingelheim’s Human Prescription Medicines R&D, provide an effective scientific environment. High-level research generates novel ideas that result in innovative products.